Suturegard

Portland, United States Founded: 2015 • Age: 11 yrs
Wound closure devices for skin are manufactured by Suturegard.
Request Access
Report Incorrect Data
Annual revenue - Latest available
Total funding $580,000 3 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Suturegard

Suturegard is a company based in Portland (United States) founded in 2015 by Jen Akeroyd and Bill Lear. Suturegard has raised $580 thousand across 3 funding rounds. Suturegard operates in a competitive market with competitors including Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Limax Biosciences, among others.

  • Headquarter Portland, United States
  • Founders Jen Akeroyd, Bill Lear
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Suturegard Medical, Inc
Operational Areas
Healthcare → Medical Devices & Diagnostics → →
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $580 K (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Suturegard

Suturegard has successfully raised a total of $580K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (14 Jan 2021)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2022 Amount Seed - Suturegard Valuation

investors
Apr, 2021 Amount Seed - Suturegard Valuation

investors
Jan, 2021 Amount Seed - Suturegard Valuation

investors

Investments & Acquisitions by Suturegard

Investments

Financial Statements - Suturegard

Suturegard Comparisons

+
Add Comparison
Available on Premium

Competitors of Suturegard

Suturegard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Limax Biosciences, among others.

Company Name Domain Founded year HQ Location Description
Adhezion Biomedical
domain founded_year HQ Location
Developer of cyanoacrylate based surgical, wound management, and infection prevention products
Inno Therapy
domain founded_year HQ Location
Hemostatic polymers are produced for surgical and wound care applications.
HyperBranch Medical
domain founded_year HQ Location
Biosurgical devices are developed using proprietary polymers and hydrogels.
BRIJ Medical
domain founded_year HQ Location
Medical devices for post-surgical and trauma incision care are provided.
Limax Biosciences
domain founded_year HQ Location
Stretchable hydrogel adhesives are developed for wound sealing and healing.

Latest news on Suturegard

Frequently Asked Questions about Suturegard

Suturegard was founded in 2015 and raised its 1st funding round 6 years after it was founded.

Suturegard is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

Dan Ladizinsky is the current CEO of Suturegard.

Suturegard is a funded company, having raised a total of $580K across 3 funding rounds to date. The company's 1st funding round was a Seed of $550K, raised on Jan 14, 2021.

Suturegard was founded in 2015 in Portland, United States, within the medical devices sector. Devices for wound closure are produced, including SutureGard, which pre-stretches skin prior to closure or serves as an alternative to skin flaps, grafts, or secondary intention healing. HemiGard is offered as an adhesive retention suture device designed for fragile skin wounds to prevent tearing during closure. Operations focus on manufacturing these products for surgical applications.

Suturegard's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available